The Skindex Instruments to Measure the Effects of Skin Disease on Quality of Life

Dermatologic Clinics

Volumn 30, Issue 2, 2012, Pages 231-236

  Chren, Mary Margaret ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Outcomes research; Patient reported outcomes; Quality of life; Skin diseases

Indexed keywords

ACNE VULGARIS; ATTITUDE TO ILLNESS; CHEMOSURGERY; CONCEPTUAL FRAMEWORK; CULTURAL FACTOR; DATA ANALYSIS; DISEASE SEVERITY; ECZEMA; ELECTROSURGERY; EMOTION; FUNCTIONAL STATUS; HUMAN; MEDICAL RESEARCH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; PSYCHOMETRY; QUALITY OF LIFE; REVIEW; SKIN CANCER; SKIN DISEASE; SKIN SURGERY; SKIN TUMOR; SKINDEX 16; SKINDEX 29; SYMPTOM; TREATMENT OUTCOME; VERRUCA VULGARIS;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SKIN DISEASES; UNITED STATES;

EID: 84856251244     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.11.003     Document Type: Review

References (32)

1. Finlay A.Y., Kelly S.E. Psoriasis: an index of disability. Clin Exp Dermatol 1987, 12:8-11.
2. Finlay A.Y., Khan G.K. Dermatology life quality index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19:210-216.
3. Kirshner B., Guyatt G. Amethodological framework for assessing health indices. JChronic Dis 1985, 38(1):27-36.
4. Chren M.M., Lasek R.J., Quinn L.M., et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. JInvest Dermatol 1996, 107:707-713.
5. Chren M.M., Lasek R.J., Flocke S.A., et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133(11):1433-1440.
6. Chren M.M., Lasek R.J., Sahay A.P., et al. Measurement properties of Skindex-16, A brief quality-of-life measure for patients with skin diseases. JCutan Med Surg 2001, 5(2):105-110.
7. Ponte M., Klemperer E., Sahay A., et al. Effects of vulvodynia on quality of life. JAm Acad Dermatol 2009, 60(1):70-76.
8. Chren M. Interpretation of quality-of-life scores. J Invest Dermatol 2011, in press.
9. Nijsten T., Sampogna F., Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009, 218(2):151-154.
10. Prinsen C.A., Lindeboom R., Sprangers M.A., et al. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. JInvest Dermatol 2010, 130:1318-1322.
11. Lasek R.J., Chren M.M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998, 134(4):454-458.
12. Sampogna F., Frontani M., Baliva G., et al. Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 2009, 160(4):815-822.
13. De Korte J., Mombers F.M., Sprangers M.A., et al. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 2002, 138(9):1221-1227. [discussion: 1227].
14. Zug K.A., Aaron D.M., Mackenzie T. Baseline quality of life as measured by Skindex-16+5 in patients presenting to a referral center for patch testing. Dermatitis 2009, 20(1):21-28.
15. Reid E.E., Haley A.C., Borovicka J.H., et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. JAm Acad Dermatol 2011, in press.
16. Maurer M., Ortonne J.P., Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009, 64(4):581-588.
17. Ortonne J.P., Ganslandt C., Tan J., et al. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial. JEur Acad Dermatol Venereol 2009, 23(8):919-926.
18. de Korte J., van der Valk P.G., Sprangers M.A., et al. Acomparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. Br J Dermatol 2008, 158(2):375-381.
19. Hayashi N., Kawashima M. Efficacy of oral antibiotics on acne vulgaris and their effects on quality of life: a multicenter randomized controlled trial using minocycline, roxithromycin and faropenem. JDermatol 2011, 38(2):111-119.
20. Gambichler T., Othlinghaus N., Tomi N.S., et al. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br J Dermatol 2009, 160(3):652-658.
21. Guillemin F., Bombardier C., Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. JClin Epidemiol 1993, 46(12):1417-1432.
22. Jones-Caballero M., Penas P.F., Garcia-Diez A., et al. The Spanish version of Skindex-29. Cultural adaptation and preliminary evidence of validity and equivalence with the original American version. Int JDermatol 2000, 39:907-912.
23. Higaki Y., Kawamoto K., Kamo T., et al. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. JDermatol 2002, 29(11):693-698.
24. Hareendran A., Doll H., Wild D.J., et al. The venous leg ulcer quality of life (VLU-QoL) questionnaire: development and psychometric validation. Wound Repair Regen 2007, 15(4):465-473.
25. Warshaw E.M., Foster J.K., Cham P.M., et al. NailQoL: a quality-of-life instrument for onychomycosis. Int J Dermatol 2007, 46(12):1279-1286.
26. Chen S.C., Yeung J., Chren M.M. Scalpdex: a quality-of-life instrument for scalp dermatitis. Arch Dermatol 2002, 138(6):803-807.
27. Smidt A.C., Lai J.S., Cella D., et al. Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease. Arch Dermatol 2010, 146(8):865-869.
28. Chren M.M., Sahay A.P., Bertenthal D.S., et al. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. JInvest Dermatol 2007, 127(6):1351-1357.
29. Chen T., Bertenthal D., Sahay A., et al. Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. Arch Dermatol 2007, 143(11):1386-1392.
30. Nijsten T.E., Sampogna F., Chren M.M., et al. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. JInvest Dermatol 2006, 126(6):1244-1250.
31. Schmitt J., Langan S., Stamm T., et al. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. JInvest Dermatol 2011, 131(3):623-630.
32. Chren M.M. Measurement of vital signs for skin diseases. JInvest Dermatol 2005, 125(4):viii-viix.